TrademarkDir
GENE WRITING
DEAD

Serial Number

90071417

Owner

TESSERA THERAPEUTICS, INC.

Attorney

Christina M. Licursi

First Use Date

Dec 3, 2021

Filing Date

Jul 24, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GENE WRITING Trademark

Serial Number: 90071417

GENE WRITING is a trademark filed by TESSERA THERAPEUTICS, INC. on July 24, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TESSERA THERAPEUTICS, INC. (10 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

July 24, 2020

Registration Date

Not Registered

First Use Anywhere

December 3, 2021

First Use in Commerce

December 3, 2021

Goods & Services

Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 28, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 27, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 27, 2023 ABN2
ASSIGNED TO EXAMINER
Dec 2, 2022 DOCK
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Sep 12, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Sep 12, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Sep 12, 2022 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2022 CNRT
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Dec 7, 2021 AAUA
USE AMENDMENT ACCEPTED
Dec 6, 2021 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2021 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Dec 4, 2021 AUPC
USE AMENDMENT FILED
Dec 4, 2021 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 3, 2021 ERFR
TEAS AMENDMENT OF USE RECEIVED
Dec 3, 2021 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 3, 2021 GNFN
FINAL REFUSAL E-MAILED
Jun 3, 2021 GNFR
FINAL REFUSAL WRITTEN
Jun 3, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 12, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 12, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2020 NWOS

Related Trademarks

More from this Owner

GENE WRITER

GENE WRITER

GENE REWRITER

GENE REWRITER

GENE REWRITER

GENE REWRITER

GENE WRITER

GENE WRITER

GENE REWRITING

GENE REWRITING

Trademark logo

Serial #88818421